Skip to main content
Livermore
Livermore
ZHEN

Fred Alger Management, LLC

SEC CIK
0000003520
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Fred Alger Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of BMRN by Fred Alger Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−3,690−100.0%Sold outHolders
Q1 20263,690$208.4K<0.1%−1,865−33.6%ReducedHolders
Q4 20255,555$330.1K<0.1%−18,145−76.6%ReducedHolders
Q3 202523,700$1.28M<0.1%−4,907−17.2%ReducedHolders
Q2 202528,607$1.57M<0.1%−196−0.7%ReducedHolders
Q1 202528,803$2.04M<0.1%+2,933+11.3%AddedHolders
Q4 202425,870$1.70M<0.1%−703−2.6%ReducedHolders
Q3 202426,573$1.87M<0.1%−2,943−10.0%ReducedHolders
Q2 202429,516$2.43M<0.1%−1,664−5.3%ReducedHolders
Q1 202431,180$2.72M<0.1%−2,209−6.6%ReducedHolders
Q4 202333,389$3.22M<0.1%−7,493−18.3%ReducedHolders
Q3 202340,882$3.62M<0.1%−6,715−14.1%ReducedHolders
Q2 202347,597$4.13M<0.1%−85,326−64.2%ReducedHolders
Q1 2023132,923$12.9M0.1%+60,297+83.0%AddedHolders
Q4 202272,626$7.52M<0.1%+33,940+87.7%AddedHolders
Q3 202238,686$3.28M<0.1%−32,718−45.8%ReducedHolders
Q2 202271,404$5.92M<0.1%−51,391−41.9%ReducedHolders
Q1 2022122,795$9.47M<0.1%−93,055−43.1%ReducedHolders
Q4 2021215,850$19.1M<0.1%+174,998+428.4%AddedHolders
Q3 202140,852$3.16M<0.1%+2,701+7.1%AddedHolders
Q2 202138,151$3.18M<0.1%+7,711+25.3%AddedHolders
Q1 202130,440$2.30M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.